Abstract: The present invention provides a medicament having a gentle but strong defecation-promoting action without causing diarrhea. That is, it provides a defecation-promoting agent comprising a compound having an adenosine A2 receptor antagonism, preferably an adenosine A2b receptor antagonism, or a salt thereof.

Abstract: The present invention provides a preventive or therapeutic agent of a new type for diabetes mellitus and diabetic complications on the basis of an adenosine A2 receptor antagonistic action. A purine compound represented by the formula (I), its pharmacologically acceptable salt or hydrates thereof has an adenosine A2 receptor antagonistic action and is useful for prevention or therapy of diabetes mellitus and diabetic complications. In addition, adenosine A2 receptor antagonists having different structures from those of the compounds described above, for example KW6002, are also effective for prevention or therapy of diabetes mellitus and diabetic complications. In the formula, W is —CH2CH2—, —CH═CH— or —C≡C—; R1 is: (in the formula, X is hydrogen atom, hydroxyl group, a lower alkyl group, a lower alkoxy group, etc.

Abstract: A glass panel, its manufacturing method and a spacer for use in the glass panel. In the glass panel, a plurality of spacers (3) are formed between and along a first opposing face (2A) of a first glass sheet (1A) and a second opposing face (2B) of a second glass sheet (1B) so as to form a space (C) therebetween, and a sealing material (6) is provided at peripheral edge (1a) of the first glass sheet (1A) and the second glass sheet (1B) for maintaining the space (C) gas-tight. The plurality of such spacers (3) having, at one side thereof, contact portions (5) capable of coming into contact with the first opposing face (2A) are provided on the second opposing face (2B). The contact portions (5) and the first opposing face (2A) are movable relative to each other.

Abstract: A double glazing having a plurality of sheet glass (1) (2) juxtaposed in the direction of thickness with spacers (3) arranged in between, peripheries of these sheet glasses (1) (2) being sealed throughout the circumference thereof. Reinforced sheet glass is employed for at least one of the plurality of sheet glasses (1) (2), and the peripheries of the sheet glasses are sealed by a sealing material having a sealing temperature below 400° C.

Abstract: A glass panel includes a pair of glass sheets (1A, 1B) having sheet faces thereof opposed to each other across a void (V) therebetween and having peripheral edges thereof bonded to each other with low-melting glass (3) to seal the void.

Abstract: A glass panel including a pair of first and second glass sheets (1A, 1B) disposed with sheet faces thereof opposed to each other, a plurality of spacers (5) being interposed between the pair of glass sheets (1A, 1B) for forming a space (4) therebetween; and a sealing material (S) for bonding peripheral edges (3) of the glass sheets (1A, 1B) together for sealing the space (4), the sealing material having a lower fusing temperature than the softening point of the glass sheets (1A, 1B). Each spacer (5) is formed by disposing spacer-forming paste (11) in a predetermined shape on the sheet face of the glass sheet (1A, 1B). Or, the spacer (5) comprises a plurality of spacer bodies (51) two-dimensionally interconnected to each other via a connecting member (52).

Abstract: A glass panel including a pair of first and second glass sheets (1A, 1B) disposed with sheet faces thereof opposed to each other, a plurality of spacers (5) being interposed between the pair of glass sheets (1A, 1B) for forming a space (4) therebetween; and a sealing material (S) for bonding peripheral edges (3) of the glass sheets (1A, 1B) together for sealing the space (4), the sealing material having a lower fusing temperature than the softening point of the glass sheets (1A, 1B). Each spacer (5) is formed by disposing spacer-forming paste (11) in a predetermined shape on the sheet face of the glass sheet (1A, 1B). Or, the spacer (5) comprises a plurality of spacer bodies (51) two-dimensionally interconnected to each other via a connecting member (52).

Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.

Abstract: A ceramic discharge vessel (8) for a high-pressure discharge lamp has a pin-like feedthrough (10) inserted in a plug (11) made from a composite material. The feedthrough (10) has been sintered directly into the plug (11) and is additionally sealed by covering the area, surrounding the feedthrough, of the plug's surface facing away from the discharge volume with a ceramic sealing material (7a).

Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.

Abstract: An oscillation switch consists of a pair of ring-shaped electrodes each having an inner surface coaxially provided with a projection and spaced apart at a predetermined distance, and balls arranged in a space formed between the electrodes so that the balls engage the projections to electrically connect the electrodes together when oscillation or lateral sliding occur. A portable electrically driven machine provided with the oscillation switch has the oscillation switch provided on a frame and has a structure which stops a tool rotating motor and a feed motor by interrupting the electric power supply to a control unit of the electric tool. The use of the oscillation switch allows the tool rotating motor or the feed motor to stop as soon as lateral sliding or oscillation starts to occur or when the portable electrically driven machine starts to fall down even if the portable electrically driven tool takes any posture.

Abstract: To provide a tight seal for a fill bore in the wall or an end plug of a dharge vessel for high-pressure discharge lamps, a fill bore is provided either through the wall--in the region of the plug--or through a plug, and the fill bore is then closed by a stopper in combination with a melt sealing material, which is so chosen that the sealing material and plug-like member combination provide a minimum of sealing material exposed to the fill in the discharge volume. The fill in the discharge volume of the discharge vessel is ionizable and, for example containing halides, is highly corrosive to the sealing material. The lamp can be made by inserting a stopper into the filling bore, applying, with the stopper in place in the filling bore, sealing material to the outer end of the filling bore, and heating the portion of the discharge vessel to liquefying temperature of the sealing material to liquefy the sealing material and hence close off the fill bore.

Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.

Abstract: A high pressure discharge lamp having an extended life includes a discharge vessel 8, and a feedthrough 10 extending through a plug 11. A directly sintered connection is formed between the feedthrough 10 and the plug 11 wherein sealing material 7 is provided covering the area surrounding the feedthrough on the outer surface of the plug 11. The plug 11 is formed of a composite material whose thermal expansion coefficient lies between that of the ceramic vessel and of the metal feedthrough.

Abstract: Disclosed are lipid A analogs useful for the treatment of septic shock and LPS-mediated activation of viral infection.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are useful in the pharmaceutical field, especially in treating allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.

Abstract: A glycerin derivative having the following formula (I) or (I') and a pharmacologically acceptable salt thereof are useful to treat diseases caused by the platelet activating factor.

Abstract: A glycerin derivative having the following formula (I) or (I') and a pharmacologically acceptable salt thereof are useful to treat diseases caused by the platelet activating factor.

Abstract: A triazolo-1,4-di-azepine compound of the below given formula and a pharmacologically acceptable salt thereof are disclosed and useful in the pharmaceutical field, especially to allergic diseases. ##STR1## in which R.sup.1 and R.sup.2 are hydrogen or an alkyl, R.sup.3 is hydrogen or a halogen, R.sup.4 is hydrogen or an alkyl, X is --OCO--, --NHCO--, --CO-- or others and Y is a cycloalkyl, a cycloalkylalkyl, an alkynyl or others.